Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Mental Health Services topic
No spam. Unsubscribe anytime.
Committee recommends three‑year trial with Care Solace to connect residents to mental‑health providers
Summary
The committee recommended a three‑year trial partnership with Care Solace, a care‑navigation service, at about $1 per resident per year (roughly $58,000 annually). The motion passed on roll call and staff said opioid settlement funds could offset costs.
The Committee of the Whole voted to recommend the Village Board partner with Care Solace on a three‑year trial basis. The motion, moved by Trustee Leaflet, asked staff to approach Orland Township, the Orland Park Library, the Orland Fire Protection District and School District 135 to solicit participation and authorized the village manager to execute related documents subject to village‑attorney review.
Staff described Care Solace as a 24/7 care navigator that helps individuals and families find mental‑health and social‑service providers via phone, text, or an anonymous online matching tool, with multi‑language support. Staff said Care Solace lists nearly 300 providers in the Orland Park area and thousands more across Cook County and Illinois.
Cost and funding: Staff said the vendor asks for $1 per resident per year—approximately $58,000 annually for Orland Park. The village has received more than $64,000 in opioid‑settlement funds to date and expects roughly $87,000 over the next 13 years; staff suggested settlement funds could offset some or all of the first‑year cost and that additional partners or grants could supplement future years.
Privacy and metrics: Staff said usage reporting provided to the village would be aggregate headcounts only (no names or identifiable information). The committee asked about outcome measures; staff said the village would track utilization and benchmark across years but that granular personal data would not be shared.
The motion passed on a unanimous roll call. Staff recommended the three‑year trial and said outreach and partnership with local organizations would be critical to drive awareness.
